Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CMOC (603993.SS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Rmb) Price Target (Rmb) Rating
2022-02-286.015.00Sell
2022-03-305.305.50Neutral
2022-10-214.264.50Neutral
2023-01-174.855.50Buy
2023-04-196.92-No Rating
2023-05-125.305.50Buy
2023-05-235.24-No Rating
2023-07-125.527.00Buy
2023-07-185.757.40Buy
2024-01-105.296.70Buy
2024-03-147.199.20Buy
2024-05-078.83-No Rating
2024-05-149.4611.00Buy
2024-08-307.499.90Buy
2025-03-248.0110.80Buy
2025-04-227.2010.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
  • Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.